Poliscio Analytics LLC
  • Home
  • Latest FOIA Insights
  • FOIAengine
    • Log In
    • User Support
    • How to Use
    • About FOIA Engine
    • Trial User Signup
  • About
    • About PoliScio
    • Leadership
  • Newsroom
  • Contact
Select Page
Mid-Year Review: FOIA Requests Show Media’s Focus on FTC

Mid-Year Review: FOIA Requests Show Media’s Focus on FTC

by Randy E. Miller | Aug 21, 2024 | Antitrust, Cryptocurrency, FOIA, FTC, News Media

FOIAengine Analysis Reveals Targets and Topics News media outlets continued to be the leading submitters of Freedom of Information Act requests to the Federal Trade Commission during the first half of 2024, with many of the requests focused on the agency’s...
Fame, Fortune and Criminal Charges for Citron’s Andrew Left

Fame, Fortune and Criminal Charges for Citron’s Andrew Left

by John A. Jenkins | Aug 14, 2024 | FOIA, Litigation, News Media, SEC, Short-Selling

FOIAengine: How the “Bounty Hunter of Wall Street” Hedged His Bets As a young man, Andrew Left was a “real serious kid” – and very religious.  He wanted to be a rabbi.  But then, in his telling, Left saw a newspaper ad that said, “Earn $100,000.”  “I thought, ‘Yeah,...
Mid-Year Review: FOIA Requests Show Media’s Focus on FTC

FTC Pursues an Oil Industry Legend, as Others Join the Hunt

by John A. Jenkins | Jul 30, 2024 | Antitrust, FOIA, FTC, Law Firms, Pharmaceuticals

FOIA Requests Target Scott Sheffield, King of the Frackers, Amid Reports of a Criminal Referral This week, we’re looking into how antitrust enforcers used their approval of an oil-industry megadeal to send a message about white-collar criminality.  It’s a cautionary...
FOIA Requests Target FTC’s PBM Investigation

FOIA Requests Target FTC’s PBM Investigation

by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals

FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
Fame, Fortune and Criminal Charges for Citron’s Andrew Left

SEC’s “Suspicion-less Investigations” Under Attack

by John A. Jenkins | Jul 17, 2024 | FOIA, Law Firms, SEC, Stock Market

The American Securities Association Uses a FOIA Lawsuit to Advance Its Agenda Two months ago, the two Republican members of the Securities and Exchange Commission blasted their own agency for what they called a meritless prosecution of stock exchanges.  In a blunt...
Fame, Fortune and Criminal Charges for Citron’s Andrew Left

“CAT” Up a Tree: Showdown Looms over SEC’s Plan for a Huge Trading Database

by John A. Jenkins | Jul 10, 2024 | FOIA, Hedge Funds, Litigation, SEC

FOIA Requests Reveal Perils and Possibilities of the Consolidated Audit Trail, aka “Mass Surveillance” Imagine a time when anyone might be able to file a Freedom of Information Act request with the Securities and Exchange Commission for a complete audit-trail report...
« Older Entries
Next Entries »
  • Terms of Service
  • Privacy Policy
Copyright 2025 PoliScio Analytics LLC